Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing

Patent metadata

Field	Value
Publication number	US-9962360-B2
Application number	US-201515513877-A
Country	US
Kind code	B2
Filing date	Sep 25, 2015
Priority date	Sep 25, 2014
Publication date	May 8, 2018
Grant date	May 8, 2018

Abstract

The invention relates to compositions and methods useful for enhancing hair growth and promoting skin regeneration. Particularly, the invention provides topical compositions including trimebutine, salts, or active metabolites thereof, for enhancing or inducing hair growth and promoting skin regeneration. Compositions comprising trimebutine or a pharmaceutically acceptable salt or active metabolite thereof and their use in the method of promoting hair growth or skin regeneration. Preferably trimebutine is trimebutine maleate or N-desmethyl trimebutine. Compositions are preferably in a form for topical administration, such as a gel.

First claim

The invention claimed is:

1. A method of promoting skin repair or wound healing comprising administering to a subject in need thereof a composition comprising an effective amount of trimebutine or a pharmaceutically acceptable salt or active metabolite thereof.

2. The method of claim 1 , wherein the trimebutine is trimebutine maleate or N-desmethyl trimebutine.

3. The method of claim 1 , wherein the subject has a burn or an ulcer, has or previously had an infection resulting in skin loss, has undergone a surgical procedure requiring skin repair, or has an injury resulting in skin loss.

4. The method of claim 1 , wherein the composition is administered until the wound substantially heals.

5. A method of promoting hair growth or treating a condition associated with hair loss comprising administering to a subject in need thereof a composition comprising an effective amount of trimebutine or a pharmaceutically acceptable salt or active metabolite thereof.

6. The method of claim 5 , wherein the trimebutine is trimebutine maleate or N-desmethyl trimebutine.

7. The method of claim 5 , wherein the condition associated with hair loss is selected from the group consisting of: androgenic alopecia, alopecia areata, anagen effluvium, self-induced hair loss, telogen effluvium, scarring alopecia, hair loss as a result of chemotherapy or radiation treatment, supplementing hair transplant, priming skull, and hair loss as a result of exposure to toxic chemicals.

8. The method of claim 5 , wherein the compositions is administered until a symptom of hair loss improves.

9. The method of claim 5 , wherein the method further comprises monitoring whether the subject experiences an improvement in hair growth.

10. The method of 1 , wherein the composition is administered with a second agent.

11. The method of claim 1 , wherein the composition is formulated for topical administration.

12. The method of claim 11 , wherein the composition comprises from about 2% (v/v) to about 20% (v/v) of trimebutine maleate.

13. The method of claim 1 , wherein the composition is formulated for oral administration.

14. The method of claim 13 , wherein the composition comprises from about 5 mg to about 100 mg of trimebutine maleate.

Assignees

• Hospital For Sick Children

Inventors

• Miller Freda D
• Kaplan David R
• Naska Sibel
• Smith Kristen Michelle
• Paris Maryline

Classifications

• A61K8/445

  aromatic, i.e. the carboxylic acid directly linked to the aromatic ring · CPC title

• A61K9/06

  Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

• A61Q7/00

  Preparations for affecting hair growth · CPC title

• A61K9/0053

  Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title

• A61K31/24 Primary

  having an amino or nitro group · CPC title